Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Jak-STAT signaling pathway (mmu04630)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
BB229853
KLA  ATP  ATP+KLA
 BB229853 gb|BB229853 RIKEN full-length enriched, 3 days neonate thymus Mus musculus cDNA clone A630023O21 3. [BB229853] KLA 6.32 5.94 6.13 6.41 7.39 12.33 6.08
ATP .39 .24 .33 .38 1.18 5.75 2.85
KLA/ATP 2.27 2.02 3.25 4.04 7.11 10.22 13.93
Bcl2l1
KLA  ATP  ATP+KLA
 NM_009743 Bcl2-like 1 (Bcl2l1), nuclear gene encoding mitochondrial protein, mRNA [NM_009743] KLA .99 1.02 1.10 1.16 1.27 .97 1.05
ATP 1.18 1.42 .81 1.26 1.51 .71 1.67
KLA/ATP 1.21 1.30 .66 1.15 1.31 1.17 1.59
Cbl
KLA  ATP  ATP+KLA
 NM_007619 Casitas B-lineage lymphoma (Cbl), mRNA [NM_007619] KLA 1.23 1.22 1.54 1.84 2.25 2.58 2.75
ATP 1.04 1.12 1.07 1.53 1.55 2.12 3.23
KLA/ATP 1.23 1.20 1.22 1.44 1.31 1.88 6.28
Cblb
KLA  ATP  ATP+KLA
 AK045005 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130018P07 product:hypothetical protein, full insert sequence. [AK045005] KLA 1.16 1.11 1.15 1.10 1.16 .98 .93
ATP 1.16 1.23 .98 1.28 1.34 .73 1.55
KLA/ATP 1.26 1.60 1.64 1.23 1.01 .91 1.05
Cblb
KLA  ATP  ATP+KLA
 AK084162 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230004I05 product:unclassifiable, full insert sequence. [AK084162] KLA .97 .98 1.02 1.01 .84 1.02 1.03
ATP 1.03 1.02 .98 1.09 1.05 .96 .96
KLA/ATP 1.07 .95 .91 .98 .98 1.01 1.00
Cblc
KLA  ATP  ATP+KLA
 NM_023224 Casitas B-lineage lymphoma c (Cblc), mRNA [NM_023224] KLA 1.02 .98 1.01 1.02 1.00 .99 1.05
ATP .94 .95 .97 1.04 .99 .97 .99
KLA/ATP 1.00 1.01 .96 .97 .94 .92 .99
Ccnd1
KLA  ATP  ATP+KLA
 S78355 gb|Cyl-1=cyclin D1 [mice, BALB/c, brain, mRNA, 3737 nt]. [S78355] KLA .24 .23 .23 .24 .29 .47 .17
ATP 1.02 1.02 .88 .80 .52 .10 .21
KLA/ATP .27 .23 .22 .24 .27 .25 .14
Ccnd2
KLA  ATP  ATP+KLA
 NM_009829 cyclin D2 (Ccnd2), mRNA [NM_009829] KLA 12.92 13.66 11.94 12.37 11.11 5.44 1.53
ATP .98 .75 .50 .57 1.24 2.83 .40
KLA/ATP 11.19 11.62 10.34 7.96 7.92 7.10 2.57
Ccnd3
KLA  ATP  ATP+KLA
 NM_007632 cyclin D3 (Ccnd3), transcript variant 1, mRNA [NM_007632] KLA .60 .65 .86 1.02 1.91 2.26 1.45
ATP 1.05 1.14 .89 1.20 .74 .76 .99
KLA/ATP .70 .67 .54 .83 .61 1.19 1.45
Cish
KLA  ATP  ATP+KLA
 NM_009895 cytokine inducible SH2-containing protein (Cish), mRNA [NM_009895] KLA 26.44 22.18 9.67 6.27 2.93 2.06 1.53
ATP 1.03 1.35 3.93 7.00 24.56 38.19 5.08
KLA/ATP 26.32 33.26 32.35 24.73 42.75 48.19 11.96
Clcf1
KLA  ATP  ATP+KLA
 NM_019952 cardiotrophin-like cytokine factor 1 (Clcf1), mRNA [NM_019952] KLA 1.48 1.45 1.55 1.52 1.55 1.40 1.32
ATP 1.04 1.05 1.19 1.85 3.78 2.93 1.44
KLA/ATP 1.59 1.68 1.51 1.76 3.88 3.35 2.61
Cntfr
KLA  ATP  ATP+KLA
 NM_016673 ciliary neurotrophic factor receptor (Cntfr), mRNA [NM_016673] KLA 1.03 1.03 1.08 1.06 1.05 .95 .95
ATP .89 .99 1.01 .96 .94 1.01 .95
KLA/ATP .93 .95 1.03 .96 1.00 .92 .95
Crebbp
KLA  ATP  ATP+KLA
 AK048818 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230072N21 product:hypothetical protein, full insert sequence [AK048818] KLA 1.44 1.19 1.26 1.25 1.25 1.36 1.24
ATP .98 .90 1.04 1.11 1.95 2.72 1.51
KLA/ATP 1.17 1.27 1.45 1.28 1.98 2.80 2.52
Crebbp
KLA  ATP  ATP+KLA
 NM_001025432 CREB binding protein (Crebbp), mRNA [NM_001025432] KLA .97 1.01 .98 1.06 1.05 .99 1.07
ATP 1.07 1.05 .96 1.01 1.15 1.14 1.00
KLA/ATP 1.01 .97 .97 1.00 1.03 1.23 1.13
Crebbp
KLA  ATP  ATP+KLA
 S66385 gb|CREB-binding protein [mice, brain, mRNA Partial, 7326 nt]. [S66385] KLA 1.00 .98 1.08 .98 1.04 1.07 1.08
ATP .99 .98 .99 1.09 1.13 1.08 1.05
KLA/ATP 1.06 1.00 1.05 1.03 1.02 1.14 1.11
Crlf2
KLA  ATP  ATP+KLA
 NM_016715 cytokine receptor-like factor 2 (Crlf2), mRNA [NM_016715] KLA 1.22 1.28 1.26 1.35 1.28 1.44 1.35
ATP .94 .87 1.11 .99 .95 1.07 .94
KLA/ATP 1.19 1.28 1.32 1.34 1.27 1.30 1.17
Csf2
KLA  ATP  ATP+KLA
 NM_009969 colony stimulating factor 2 (granulocyte-macrophage) (Csf2), mRNA [NM_009969] KLA 1.44 1.53 1.38 1.37 1.15 1.21 1.14
ATP 1.01 1.02 1.85 9.73 2.64 1.90 1.14
KLA/ATP 1.49 1.84 2.14 2.80 1.67 1.36 1.35
Csf2ra
KLA  ATP  ATP+KLA
 NM_009970 colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) (Csf2ra), mRNA [NM_009970] KLA 1.10 1.06 1.03 1.13 1.24 1.35 1.09
ATP .89 .87 .95 .81 .86 1.10 1.06
KLA/ATP .94 .98 1.22 1.02 1.18 1.11 1.22
Csf2rb
KLA  ATP  ATP+KLA
 NM_007780 colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) (Csf2rb), mRNA [NM_007780] KLA 1.35 1.52 1.85 1.87 2.61 2.52 2.54
ATP 1.09 1.15 1.08 1.83 6.59 6.78 7.07
KLA/ATP 1.55 1.66 1.38 2.67 6.21 6.94 6.57
Csf2rb2
KLA  ATP  ATP+KLA
 NM_007781 colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) (Csf2rb2), mRNA [NM_007781] KLA .78 .77 .81 1.04 1.45 1.45 1.91
ATP 1.12 1.03 .89 1.11 6.65 7.45 8.58
KLA/ATP .87 .87 .84 1.09 4.89 7.15 8.83
Csf3
KLA  ATP  ATP+KLA
 NM_009971 colony stimulating factor 3 (granulocyte) (Csf3), mRNA [NM_009971] KLA 1.44 1.56 2.06 2.25 2.97 1.58 1.55
ATP 1.04 1.05 1.14 2.18 4.85 7.52 1.83
KLA/ATP 1.54 1.93 2.57 4.75 3.85 3.95 7.39
Csf3r
KLA  ATP  ATP+KLA
 NM_007782 colony stimulating factor 3 receptor (granulocyte) (Csf3r), mRNA [NM_007782] KLA 4.44 4.65 6.62 6.79 9.58 9.08 7.39
ATP 1.27 1.26 1.06 1.43 1.13 1.07 1.28
KLA/ATP 5.07 5.53 4.84 7.70 3.86 3.49 7.22
Ctf1
KLA  ATP  ATP+KLA
 NM_007795 cardiotrophin 1 (Ctf1), mRNA [NM_007795] KLA 1.00 1.05 1.06 .92 .96 .97 .93
ATP .93 .93 1.01 .96 1.00 .92 1.02
KLA/ATP 1.00 1.07 .98 .99 .87 .90 .87
Ep300
KLA  ATP  ATP+KLA
 AK042627 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730011L11 product:P300 TRANSCRIPTION COACTIVATOR (FRAGMENT) homolog [Mus sp], full insert sequence. [AK042627] KLA 1.02 .95 .92 1.04 1.01 1.00 1.05
ATP 1.06 .89 .88 .89 1.00 .90 1.07
KLA/ATP 1.10 1.02 .87 .91 1.04 .97 .98
Ep300
KLA  ATP  ATP+KLA
 NM_177821 E1A binding protein p300 (Ep300), mRNA [NM_177821] KLA 1.61 1.26 1.57 1.38 1.78 1.41 1.40
ATP 1.34 1.60 1.11 1.08 1.16 1.05 1.15
KLA/ATP 1.86 1.94 1.18 1.56 1.71 1.42 2.05
Epo
KLA  ATP  ATP+KLA
 NM_007942 erythropoietin (Epo), mRNA [NM_007942] KLA 1.00 1.05 1.08 1.01 1.03 1.08 1.04
ATP .95 .97 .97 1.04 1.02 .99 1.01
KLA/ATP 1.03 1.01 .97 1.00 1.00 1.10 1.00
Epor
KLA  ATP  ATP+KLA
 NM_010149 erythropoietin receptor (Epor), mRNA [NM_010149] KLA .57 .56 .59 .66 .59 .52 .36
ATP 1.06 1.01 1.00 .95 .73 .52 .40
KLA/ATP .57 .53 .70 .66 .72 .62 .34
Gh
KLA  ATP  ATP+KLA
 NM_008117 growth hormone (Gh), mRNA [NM_008117] KLA 1.02 1.03 1.01 .98 .98 .94 .98
ATP .94 1.02 1.06 1.20 .99 .95 .96
KLA/ATP .97 1.03 1.03 1.09 .96 1.00 1.05
Ghr
KLA  ATP  ATP+KLA
 AK053579 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111P21 product:growth hormone receptor, full insert sequence. [AK053579] KLA 1.10 1.07 1.09 1.01 1.03 .96 1.02
ATP 1.04 1.01 1.06 .96 1.03 .96 1.02
KLA/ATP 1.08 1.15 1.15 1.04 1.02 1.07 1.03
Ghr
KLA  ATP  ATP+KLA
 NM_010284 growth hormone receptor (Ghr), transcript variant 1, mRNA [NM_010284] KLA 1.09 1.10 1.29 1.31 1.23 1.09 .97
ATP 1.00 1.02 1.03 1.02 .93 .96 .97
KLA/ATP 1.17 1.20 1.15 1.15 1.07 .96 .96
Grb2
KLA  ATP  ATP+KLA
 NM_008163 growth factor receptor bound protein 2 (Grb2), mRNA [NM_008163] KLA .92 .88 .90 1.27 1.43 1.22 1.00
ATP 1.02 .83 .51 .42 .92 .70 .57
KLA/ATP .84 .77 .61 .56 1.56 1.49 .52
Grb2
KLA  ATP  ATP+KLA
 U07617 Grb2 adaptor protein (grb2) mRNA, complete cds. [U07617] KLA .83 .80 .95 1.13 1.38 1.36 1.06
ATP .84 .74 .51 .41 .82 .74 .59
KLA/ATP .77 .70 .57 .54 1.49 1.39 .53
Ifna12
KLA  ATP  ATP+KLA
 NM_177361 interferon alpha 12 (Ifna12), mRNA [NM_177361] KLA 1.25 1.26 1.34 1.16 1.06 1.10 1.09
ATP 1.01 .97 1.07 1.09 1.17 1.20 1.07
KLA/ATP 1.12 1.29 1.72 1.54 1.59 1.56 1.05
Ifna13
KLA  ATP  ATP+KLA
 NM_177347 interferon alpha 13 (Ifna13), mRNA [NM_177347] KLA 1.32 1.27 1.26 1.34 1.15 1.24 1.20
ATP .95 1.08 1.29 1.79 1.41 1.22 1.08
KLA/ATP 1.36 1.35 2.04 2.81 2.07 1.44 1.19
Ifna2
KLA  ATP  ATP+KLA
 K01411 gb|Mouse alpha-interferon (MuIFN-alpha), 3 cds & untranslated mRNA [K01411] KLA 1.02 1.03 1.10 .96 .93 .99 1.01
ATP 1.02 .98 1.00 .98 1.02 .97 .95
KLA/ATP 1.02 1.04 1.18 1.08 1.13 1.04 1.01
Ifna2
KLA  ATP  ATP+KLA
 NM_010503 interferon alpha 2 (Ifna2), mRNA [NM_010503] KLA 1.08 1.06 1.07 1.06 .98 1.02 1.05
ATP .94 1.06 1.11 1.30 1.24 1.25 1.21
KLA/ATP 1.03 1.20 1.19 1.35 1.52 1.60 1.18
Ifna4
KLA  ATP  ATP+KLA
 NM_010504 interferon alpha 4 (Ifna4), mRNA [NM_010504] KLA .99 1.04 1.05 .97 1.00 .96 .99
ATP 1.01 .96 .98 1.01 1.00 1.00 .97
KLA/ATP 1.10 1.09 1.05 1.04 1.01 .97 1.01
Ifna5
KLA  ATP  ATP+KLA
 NM_010505 interferon alpha 5 (Ifna5), mRNA [NM_010505] KLA 1.15 1.23 1.51 1.26 1.03 1.06 1.05
ATP .99 .94 1.11 1.00 1.09 1.07 1.03
KLA/ATP 1.12 1.29 1.46 1.47 1.24 1.32 1.03
Ifna9
KLA  ATP  ATP+KLA
 NM_010507 interferon alpha 9 (Ifna9), mRNA [NM_010507] KLA 1.05 1.09 1.20 1.06 1.08 1.06 1.02
ATP .99 1.08 1.18 1.21 1.09 .99 .97
KLA/ATP 1.09 1.23 1.19 1.24 1.18 1.16 1.04
Ifnab
KLA  ATP  ATP+KLA
 BC116864 interferon alpha B, mRNA (cDNA clone MGC:151241 IMAGE:40126183), complete cds [BC116864] KLA 1.20 1.33 1.29 1.30 1.20 1.20 1.08
ATP .99 .99 1.00 1.25 1.13 1.19 1.04
KLA/ATP 1.30 1.39 1.44 1.48 1.49 1.54 1.22
Ifnar1
KLA  ATP  ATP+KLA
 NM_010508 interferon (alpha and beta) receptor 1 (Ifnar1), mRNA [NM_010508] KLA 1.35 1.29 1.19 1.39 1.60 1.47 1.49
ATP 1.18 1.25 .94 1.06 1.07 1.48 1.52
KLA/ATP 1.56 1.57 .98 1.43 1.08 1.79 3.54
Ifnar2
KLA  ATP  ATP+KLA
 NM_010509 interferon (alpha and beta) receptor 2 (Ifnar2), transcript variant 1, mRNA [NM_010509] KLA 1.45 1.43 1.67 1.87 2.31 1.84 1.36
ATP .99 .92 .87 1.03 1.38 1.79 1.43
KLA/ATP 1.48 1.48 1.24 1.54 1.77 2.10 2.81
Ifnb1
KLA  ATP  ATP+KLA
 NM_010510 interferon beta 1, fibroblast (Ifnb1), mRNA [NM_010510] KLA 49.82 46.57 34.05 16.05 5.94 7.31 8.49
ATP .99 1.02 1.89 4.78 6.31 4.44 1.79
KLA/ATP 49.22 61.83 134.08 144.05 110.96 31.78 11.24
Ifne1
KLA  ATP  ATP+KLA
 NM_177348 interferon epsilon 1 (Ifne1), mRNA [NM_177348] KLA .99 1.04 1.00 1.00 1.02 .96 .90
ATP .93 .96 1.00 1.06 .96 1.07 .96
KLA/ATP 1.07 1.01 1.02 1.01 .89 .95 1.04
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Ifngr1
KLA  ATP  ATP+KLA
 NM_010511 interferon gamma receptor 1 (Ifngr1), mRNA [NM_010511] KLA .81 .60 .37 .35 .34 .39 .54
ATP 1.05 .96 1.15 .97 .80 .67 .45
KLA/ATP .57 .57 .63 .36 .28 .33 .36
Ifngr2
KLA  ATP  ATP+KLA
 NM_008338 interferon gamma receptor 2 (Ifngr2), mRNA [NM_008338] KLA 1.45 1.49 1.74 2.22 3.22 2.42 1.96
ATP 1.11 1.03 .81 .78 1.12 1.28 1.34
KLA/ATP 1.48 1.41 1.17 1.23 1.48 1.89 2.13
Ifnk
KLA  ATP  ATP+KLA
 NM_199157 interferon kappa (Ifnk), mRNA [NM_199157] KLA 1.04 1.03 1.05 1.06 1.04 1.05 1.04
ATP 1.04 1.00 .98 1.05 .98 1.09 1.03
KLA/ATP 1.10 1.03 1.01 1.02 .95 1.03 1.01
Il10
KLA  ATP  ATP+KLA
 NM_010548 interleukin 10 (Il10), mRNA [NM_010548] KLA 17.59 18.64 22.22 23.06 11.83 8.27 2.07
ATP 1.86 3.22 7.72 20.51 25.86 8.38 1.01
KLA/ATP 17.91 23.49 34.53 34.48 20.98 12.03 8.17
Il10ra
KLA  ATP  ATP+KLA
 NM_008348 interleukin 10 receptor, alpha (Il10ra), mRNA [NM_008348] KLA 4.92 4.49 5.29 3.79 4.00 3.02 1.77
ATP 1.15 1.13 1.19 1.16 2.95 1.73 .80
KLA/ATP 5.70 4.92 6.13 3.01 4.78 3.11 2.37
Il10rb
KLA  ATP  ATP+KLA
 AF440787 C57BL [AF440787] KLA .71 .67 .65 .81 1.20 1.50 1.07
ATP 1.03 1.04 1.01 1.12 .84 .85 1.52
KLA/ATP .67 .68 .70 .82 .92 1.23 1.83
Il10rb
KLA  ATP  ATP+KLA
 AK018347 12 days embryo female ovary cDNA, RIKEN full-length enriched library, clone:6620401D04 product:unclassifiable, full insert sequence. [AK018347] KLA .89 1.00 1.05 1.07 1.29 1.12 .96
ATP .91 .73 1.23 1.43 .98 1.06 .92
KLA/ATP .86 .83 1.13 1.41 1.24 1.11 1.13
Il11
KLA  ATP  ATP+KLA
 NM_008350 interleukin 11 (Il11), mRNA [NM_008350] KLA .98 1.04 1.03 1.03 .96 1.01 1.02
ATP .94 .97 1.07 1.15 1.18 1.19 1.09
KLA/ATP 1.03 1.10 1.06 1.29 1.72 2.17 1.23
Il11ra1
KLA  ATP  ATP+KLA
 NM_010549 interleukin 11 receptor, alpha chain 1 (Il11ra1), mRNA [NM_010549] KLA .65 .63 .59 .66 .66 .75 .57
ATP .93 .86 1.11 1.02 1.65 2.34 1.14
KLA/ATP .56 .66 .88 .71 1.75 2.07 1.00
Il12a
KLA  ATP  ATP+KLA
 NM_008351 interleukin 12a (Il12a), mRNA [NM_008351] KLA 2.37 2.47 2.17 1.49 1.46 1.12 1.20
ATP 1.01 .97 1.12 1.07 1.02 1.07 1.06
KLA/ATP 2.01 2.76 2.54 1.70 1.08 1.10 1.27
Il12b
KLA  ATP  ATP+KLA
 NM_008352 interleukin 12b (Il12b), mRNA [NM_008352] KLA 194.79 211.32 198.97 173.01 142.24 40.28 3.10
ATP 1.05 1.10 1.59 1.99 2.71 2.72 1.52
KLA/ATP 191.27 223.23 280.10 224.29 183.03 68.43 10.69
Il12rb1
KLA  ATP  ATP+KLA
 NM_008353 interleukin 12 receptor, beta 1 (Il12rb1), mRNA [NM_008353] KLA 5.45 6.11 10.84 11.19 11.06 13.02 9.19
ATP .93 1.01 1.29 1.30 1.15 3.27 10.16
KLA/ATP 5.71 6.16 7.00 5.38 5.70 5.81 11.01
Il12rb2
KLA  ATP  ATP+KLA
 NM_008354 interleukin 12 receptor, beta 2 (Il12rb2), mRNA [NM_008354] KLA .93 1.02 1.05 1.02 .81 .77 .65
ATP 1.12 1.17 1.00 1.10 .87 .75 .57
KLA/ATP 1.08 1.13 .84 1.04 .81 .80 .58
Il13
KLA  ATP  ATP+KLA
 NM_008355 interleukin 13 (Il13), mRNA [NM_008355] KLA 1.08 1.05 .98 1.10 1.01 1.03 1.02
ATP 1.00 .98 1.08 .98 .99 1.05 .97
KLA/ATP .96 .96 1.09 1.02 1.04 1.01 .97
Il13ra1
KLA  ATP  ATP+KLA
 NM_133990 interleukin 13 receptor, alpha 1 (Il13ra1), mRNA [NM_133990] KLA 11.37 13.15 17.62 17.27 15.33 10.98 1.55
ATP .99 1.05 1.34 1.48 1.33 3.42 5.64
KLA/ATP 13.26 14.21 15.25 14.77 11.07 9.20 10.89
Il13ra2
KLA  ATP  ATP+KLA
 NM_008356 interleukin 13 receptor, alpha 2 (Il13ra2), mRNA [NM_008356] KLA .96 1.01 1.00 1.04 .98 1.01 .95
ATP 1.05 .98 .93 1.00 .96 .97 .98
KLA/ATP 1.05 .98 1.00 1.00 .88 .98 1.02
Il15
KLA  ATP  ATP+KLA
 AB022307 mRNA for shorter isoform of interleukin 15, partial cds. [AB022307] KLA 13.11 12.14 12.05 8.72 4.50 3.62 1.70
ATP 1.04 1.05 1.94 1.72 1.74 3.48 1.69
KLA/ATP 13.23 13.71 21.01 21.43 21.51 10.85 4.55
Il15
KLA  ATP  ATP+KLA
 NM_008357 interleukin 15 (Il15), mRNA [NM_008357] KLA 28.44 24.75 23.34 20.83 11.02 7.27 2.51
ATP 1.00 .96 1.22 1.21 1.24 4.27 1.85
KLA/ATP 24.24 23.93 33.47 31.76 21.73 10.79 11.23
Il15ra
KLA  ATP  ATP+KLA
 NM_008358 interleukin 15 receptor, alpha chain (Il15ra), transcript variant 1, mRNA [NM_008358] KLA 8.74 9.57 10.15 8.79 7.56 7.63 3.77
ATP .96 .93 1.02 1.07 2.02 3.73 1.46
KLA/ATP 9.56 10.41 10.94 10.62 11.08 9.82 8.07
Il19
KLA  ATP  ATP+KLA
 NM_001009940 interleukin 19 (Il19), mRNA [NM_001009940] KLA 6.74 6.59 7.45 8.17 6.81 3.16 1.40
ATP 1.09 1.01 1.26 2.37 3.94 10.69 1.40
KLA/ATP 6.42 6.47 6.34 7.69 7.34 8.99 4.83
Il2
KLA  ATP  ATP+KLA
 NM_008366 interleukin 2 (Il2), mRNA [NM_008366] KLA .96 .97 .96 1.00 .97 .97 .99
ATP 1.04 1.02 1.00 1.03 .97 .98 .97
KLA/ATP 1.01 .98 .97 1.00 .97 .97 .96
Il20
KLA  ATP  ATP+KLA
 NM_021380 interleukin 20 (Il20), mRNA [NM_021380] KLA 1.02 1.03 1.00 1.06 1.06 .94 .88
ATP 1.02 1.05 .88 .99 1.02 1.06 1.13
KLA/ATP .97 .94 1.05 1.07 1.11 1.03 1.07
Il20ra
KLA  ATP  ATP+KLA
 NM_172786 interleukin 20 receptor, alpha (Il20ra), mRNA [NM_172786] KLA 1.02 .95 .93 1.00 .97 .98 .98
ATP 1.02 .93 1.00 1.04 .97 1.03 1.01
KLA/ATP .99 .96 .88 .94 1.03 1.06 .93
Il20rb
KLA  ATP  ATP+KLA
 AK076401 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732496H22 product:unclassifiable, full insert sequence [AK076401] KLA 2.19 1.90 1.55 1.56 1.92 1.41 1.23
ATP 1.21 1.28 1.40 1.68 3.23 2.30 1.11
KLA/ATP 2.99 4.07 3.95 2.16 3.27 3.03 2.09
Il20rb
KLA  ATP  ATP+KLA
 NM_001033543 interleukin 20 receptor beta (Il20rb), mRNA [NM_001033543] KLA 7.23 6.19 4.74 4.77 3.85 3.07 2.30
ATP .95 .81 2.35 3.50 4.35 6.84 1.75
KLA/ATP 6.38 6.46 11.52 10.85 7.62 8.70 6.09
Il21
KLA  ATP  ATP+KLA
 NM_021782 interleukin 21 (Il21), mRNA [NM_021782] KLA .96 .99 1.01 1.01 .99 .99 .97
ATP .94 .95 1.07 .93 1.02 .96 1.00
KLA/ATP .95 .97 .98 1.04 1.01 1.06 1.00
Il21r
KLA  ATP  ATP+KLA
 NM_021887 interleukin 21 receptor (Il21r), mRNA [NM_021887] KLA .72 .87 1.22 1.88 2.63 3.16 1.00
ATP 1.01 .87 .81 .73 .82 3.86 3.67
KLA/ATP .76 .76 .97 .96 3.46 5.23 3.39
Il22
KLA  ATP  ATP+KLA
 NM_016971 interleukin 22 (Il22), mRNA [NM_016971] KLA .98 .98 .98 1.00 1.01 1.07 .98
ATP 1.03 1.03 .99 .99 1.01 .96 .99
KLA/ATP .94 1.05 1.00 1.00 .97 1.08 .96
Il22ra1
KLA  ATP  ATP+KLA
 NM_178257 interleukin 22 receptor, alpha 1 (Il22ra1), mRNA [NM_178257] KLA 1.04 .96 1.04 .99 1.01 1.01 .97
ATP .91 1.01 1.00 .99 .99 1.03 .98
KLA/ATP 1.04 1.02 1.00 1.00 .95 .94 .96
Il22ra2
KLA  ATP  ATP+KLA
 NM_178258 interleukin 22 receptor, alpha 2 (Il22ra2), mRNA [NM_178258] KLA .99 .92 1.03 1.04 1.02 1.05 1.01
ATP 1.06 1.00 1.00 1.09 1.01 .99 1.00
KLA/ATP .98 1.09 1.05 1.02 1.05 1.03 .99
Il23a
KLA  ATP  ATP+KLA
 NM_031252 interleukin 23, alpha subunit p19 (Il23a), mRNA [NM_031252] KLA 1.36 1.46 1.33 1.20 1.05 1.04 1.02
ATP .99 1.01 1.06 1.36 1.25 1.07 1.02
KLA/ATP 1.52 1.62 1.48 1.60 1.23 1.12 1.07
Il23r
KLA  ATP  ATP+KLA
 NM_144548 interleukin 23 receptor (Il23r), mRNA [NM_144548] KLA 1.40 1.33 1.51 1.62 2.19 3.40 4.65
ATP 1.10 1.03 1.01 .98 .98 1.06 1.08
KLA/ATP 1.26 1.45 1.38 1.38 1.23 1.38 4.41
Il24
KLA  ATP  ATP+KLA
 NM_053095 interleukin 24 (Il24), mRNA [NM_053095] KLA 1.00 .99 1.06 1.03 1.02 1.03 .98
ATP 1.02 .98 1.08 1.01 1.05 1.04 .98
KLA/ATP .96 1.04 1.08 1.00 1.05 .97 .97
Il28b
KLA  ATP  ATP+KLA
 NM_177396 interleukin 28B (Il28b), mRNA [NM_177396] KLA 1.05 1.07 .95 1.00 .99 .96 .90
ATP .93 .99 1.01 .92 .94 1.08 1.00
KLA/ATP .97 .97 1.12 1.02 .91 .96 .95
Il28ra
KLA  ATP  ATP+KLA
 NM_174851 interleukin 28 receptor alpha (Il28ra), mRNA [NM_174851] KLA 1.00 .85 .97 .95 .99 .98 .99
ATP 1.05 .99 1.06 .94 1.02 .99 1.09
KLA/ATP .90 1.01 1.02 .89 .99 .99 1.07
Il2ra
KLA  ATP  ATP+KLA
 AF054581 interleukin 2 receptor mRNA, 3UTR, partial sequence. [AF054581] KLA 1.76 2.05 2.73 2.46 3.58 2.68 1.13
ATP .99 .99 1.00 1.09 1.13 1.14 1.03
KLA/ATP 1.93 2.11 1.32 2.27 1.87 2.13 1.37
Il2ra
KLA  ATP  ATP+KLA
 NM_008367 interleukin 2 receptor, alpha chain (Il2ra), mRNA [NM_008367] KLA 1.33 1.29 1.46 1.43 1.82 1.57 1.15
ATP 1.02 1.03 1.01 1.02 1.01 1.12 1.05
KLA/ATP 1.30 1.46 1.36 1.41 1.22 1.47 1.66
Il2rb
KLA  ATP  ATP+KLA
 NM_008368 interleukin 2 receptor, beta chain (Il2rb), mRNA [NM_008368] KLA .92 1.00 1.00 1.00 .91 .98 1.09
ATP 1.02 .98 1.00 .95 1.02 1.04 1.04
KLA/ATP 1.03 .98 1.01 .99 .94 1.13 1.00
Il2rg
KLA  ATP  ATP+KLA
 NM_013563 interleukin 2 receptor, gamma chain (Il2rg), mRNA [NM_013563] KLA 2.97 2.92 3.73 3.39 4.04 3.45 4.83
ATP 1.25 1.41 1.04 1.82 1.48 1.12 2.89
KLA/ATP 3.65 4.34 2.42 4.70 2.62 2.54 5.15
Il3
KLA  ATP  ATP+KLA
 NM_010556 interleukin 3 (Il3), mRNA [NM_010556] KLA 1.05 .94 1.01 .99 1.03 1.07 .95
ATP .95 1.03 1.03 .98 .98 .97 .96
KLA/ATP 1.02 1.03 1.02 .94 .97 1.02 1.04
Il3ra
KLA  ATP  ATP+KLA
 NM_008369 interleukin 3 receptor, alpha chain (Il3ra), mRNA [NM_008369] KLA 1.23 1.35 1.52 1.31 1.38 1.42 1.35
ATP 1.04 1.20 1.11 1.42 1.18 .94 .77
KLA/ATP 1.33 1.45 1.45 1.69 1.25 1.22 1.32
Il4
KLA  ATP  ATP+KLA
 NM_021283 interleukin 4 (Il4), mRNA [NM_021283] KLA .94 .95 .91 .94 .91 .94 1.07
ATP 1.02 1.06 1.05 1.22 1.12 1.10 1.26
KLA/ATP .92 .96 .93 1.08 .98 1.03 1.18
Il4ra
KLA  ATP  ATP+KLA
 NM_001008700 interleukin 4 receptor, alpha (Il4ra), mRNA [NM_001008700] KLA 4.65 4.81 8.69 11.26 14.81 9.10 1.64
ATP .97 .88 .64 .58 3.81 9.28 4.93
KLA/ATP 4.86 4.84 5.43 3.60 4.37 10.35 6.16
Il5
KLA  ATP  ATP+KLA
 NM_010558 interleukin 5 (Il5), mRNA [NM_010558] KLA 1.10 1.11 1.10 .98 1.01 .98 .97
ATP .94 1.04 1.08 .92 .97 1.02 1.03
KLA/ATP .98 .92 1.12 1.03 1.02 1.00 1.03
Il5ra
KLA  ATP  ATP+KLA
 NM_008370 interleukin 5 receptor, alpha (Il5ra), mRNA [NM_008370] KLA 1.09 1.05 1.10 1.06 .98 1.00 .97
ATP .95 1.02 .99 .97 .99 1.01 .99
KLA/ATP .99 1.06 1.09 1.00 1.03 .99 1.07
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Il6ra
KLA  ATP  ATP+KLA
 NM_010559 interleukin 6 receptor, alpha (Il6ra), mRNA [NM_010559] KLA .50 .53 .65 .86 1.36 1.72 1.00
ATP .97 1.20 1.17 1.25 .74 .67 .95
KLA/ATP .50 .60 .61 .64 .59 .76 1.14
Il6st
KLA  ATP  ATP+KLA
 NM_010560 interleukin 6 signal transducer (Il6st), mRNA [NM_010560] KLA .31 .30 .36 .34 .33 .35 .42
ATP 1.16 1.12 .82 .62 1.58 1.85 1.25
KLA/ATP .38 .37 .30 .27 .78 1.56 .98
Il7
KLA  ATP  ATP+KLA
 AK041403 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630007F02 product:interleukin 7, full insert sequence [AK041403] KLA .96 .96 .97 1.00 1.01 .97 1.08
ATP 1.05 1.00 .98 .99 .94 .98 .95
KLA/ATP 1.05 1.05 .96 .99 .94 .99 .92
Il7
KLA  ATP  ATP+KLA
 NM_008371 interleukin 7 (Il7), mRNA [NM_008371] KLA 1.29 1.38 1.32 1.39 1.24 1.40 1.26
ATP 1.01 .98 1.02 .98 1.03 1.10 1.08
KLA/ATP 1.22 1.31 1.17 1.20 1.04 1.21 1.32
Il7r
KLA  ATP  ATP+KLA
 AK041838 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630041A17 product:interleukin 7 receptor, full insert sequence. [AK041838] KLA .90 1.04 .92 .95 .90 1.05 .99
ATP .97 1.01 1.11 1.04 1.06 1.33 2.92
KLA/ATP .98 .97 .91 1.10 1.06 1.20 1.57
Il7r
KLA  ATP  ATP+KLA
 NM_008372 interleukin 7 receptor (Il7r), mRNA [NM_008372] KLA .42 .40 .37 .41 .36 .60 .73
ATP 1.02 1.01 1.23 1.13 1.72 2.94 7.90
KLA/ATP .40 .41 .53 .58 1.00 2.18 4.13
Il9
KLA  ATP  ATP+KLA
 NM_008373 interleukin 9 (Il9), mRNA [NM_008373] KLA .97 1.02 1.06 1.03 1.04 1.02 1.05
ATP .98 .93 .98 1.03 1.02 1.04 .96
KLA/ATP 1.01 1.00 1.00 1.06 1.06 1.04 1.07
Il9r
KLA  ATP  ATP+KLA
 NM_008374 interleukin 9 receptor (Il9r), mRNA [NM_008374] KLA 1.01 1.02 1.01 1.02 1.01 1.01 .94
ATP .97 1.03 1.01 .94 .98 1.05 1.02
KLA/ATP 1.02 .95 1.01 1.03 1.01 .95 1.04
Irf9
KLA  ATP  ATP+KLA
 NM_008394 interferon regulatory factor 9 (Irf9), mRNA [NM_008394] KLA 1.96 1.99 2.13 1.83 1.81 1.85 1.71
ATP 1.08 1.06 .96 1.19 1.21 2.33 2.42
KLA/ATP 2.31 2.30 1.92 2.85 2.29 3.20 4.37
Jak1
KLA  ATP  ATP+KLA
 AK029232 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831433J01 product:Janus kinase 1, full insert sequence. [AK029232] KLA 1.25 1.13 1.19 1.31 1.24 1.17 1.14
ATP 1.01 1.11 .96 1.38 1.06 1.26 1.05
KLA/ATP 1.19 1.29 1.27 1.59 1.18 1.38 1.24
Jak1
KLA  ATP  ATP+KLA
 NM_146145 Janus kinase 1 (Jak1), mRNA [NM_146145] KLA 1.71 1.75 1.79 1.81 1.72 1.37 1.21
ATP 1.03 1.01 .75 1.04 1.32 1.90 1.14
KLA/ATP 1.84 1.73 1.49 2.07 2.01 1.83 1.68
Jak2
KLA  ATP  ATP+KLA
 NM_008413 Janus kinase 2 (Jak2), transcript variant 1, mRNA [NM_008413] KLA 14.86 15.05 15.42 14.15 11.46 8.81 5.47
ATP .99 1.06 1.09 1.43 2.83 4.71 1.62
KLA/ATP 13.77 14.74 14.94 12.97 7.53 9.34 9.17
Jak3
KLA  ATP  ATP+KLA
 NM_010589 Janus kinase 3 (Jak3), mRNA [NM_010589] KLA 1.46 1.56 1.79 1.62 2.05 1.72 1.65
ATP 1.11 1.19 .84 1.25 .82 .61 .71
KLA/ATP 1.76 1.82 1.10 1.74 .93 .83 1.01
Lep
KLA  ATP  ATP+KLA
 NM_008493 leptin (Lep), mRNA [NM_008493] KLA .99 1.00 1.00 .99 .99 .99 1.00
ATP 1.01 1.00 .98 1.01 1.01 .99 .98
KLA/ATP 1.01 1.02 1.01 .97 1.00 1.00 .99
Lepr
KLA  ATP  ATP+KLA
 NM_001122899 leptin receptor (Lepr), transcript variant 3, mRNA [NM_001122899] KLA .98 1.05 1.00 1.03 .98 1.01 1.10
ATP 1.07 .99 .98 1.06 1.08 1.02 1.02
KLA/ATP 1.07 1.03 .99 1.11 1.03 1.12 .98
Lepr
KLA  ATP  ATP+KLA
 NM_010704 leptin receptor (Lepr), transcript variant 2, mRNA [NM_010704] KLA 1.01 1.01 1.03 .99 1.01 1.02 .99
ATP .98 1.00 1.02 1.02 1.02 1.02 1.01
KLA/ATP 1.00 1.00 1.02 1.03 1.00 1.01 .98
Lifr
KLA  ATP  ATP+KLA
 NM_013584 leukemia inhibitory factor receptor (Lifr), transcript variant 1, mRNA [NM_013584] KLA .75 .76 .74 .72 .58 .43 .36
ATP .96 .90 .79 .71 .65 .69 .36
KLA/ATP .73 .69 .72 .68 .65 .53 .36
Mm.12688
5
KLA  ATP  ATP+KLA
 34328248 Unknown KLA .34 .32 .25 .32 .32 .39 .63
ATP 1.05 1.19 1.42 1.13 .60 .53 .59
KLA/ATP .30 .27 .37 .35 .38 .32 .38
Mm.19345
1
KLA  ATP  ATP+KLA
 141802044 Unknown KLA .67 .64 .57 .63 .57 .75 .54
ATP .88 .81 1.15 .97 1.46 2.27 1.19
KLA/ATP .55 .60 .84 .67 1.75 2.01 .95
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.24936
4
KLA  ATP  ATP+KLA
 133892283 Unknown KLA 1.42 1.41 1.61 2.14 2.88 2.49 2.03
ATP .98 .98 .76 .77 1.09 1.23 1.28
KLA/ATP 1.32 1.32 1.07 1.12 1.38 1.85 1.95
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.26687
1
KLA  ATP  ATP+KLA
 80978931 Unknown KLA .67 .63 .70 .83 1.66 1.43 1.54
ATP 1.20 1.24 1.22 1.26 1.80 .81 1.02
KLA/ATP .63 .56 .83 1.06 1.26 .70 1.34
Mm.27304
9
KLA  ATP  ATP+KLA
 119672895 Unknown KLA .23 .22 .22 .22 .30 .51 .16
ATP 1.08 1.05 .88 .78 .47 .09 .20
KLA/ATP .28 .22 .21 .24 .26 .22 .12
Mm.28722
8
KLA  ATP  ATP+KLA
 160707972 Unknown KLA 1.08 1.08 1.05 1.13 1.29 1.37 1.09
ATP 1.04 .96 1.15 .83 .88 1.18 1.09
KLA/ATP 1.06 .86 1.30 1.05 1.19 1.00 1.19
Mm.29766
6
KLA  ATP  ATP+KLA
 84490380 Unknown KLA .80 .86 .83 .84 .86 .74 .83
ATP 1.07 1.00 1.08 .98 .95 1.15 .98
KLA/ATP .82 .89 .96 .90 .90 .91 .81
Mm.35771
KLA  ATP  ATP+KLA
 141802359 Unknown KLA 1.27 1.19 1.20 1.42 1.30 1.42 1.36
ATP .92 .84 1.11 1.08 .99 1.01 .91
KLA/ATP 1.09 1.12 1.37 1.35 1.32 1.25 1.23
Mm.36833
0
KLA  ATP  ATP+KLA
 142345552 Unknown KLA .94 .98 1.01 .97 1.00 1.07 1.02
ATP .95 1.00 .97 1.03 1.07 1.00 .99
KLA/ATP .98 1.00 .85 1.07 1.10 1.07 .98
Mm.37708
7
KLA  ATP  ATP+KLA
 158631169 Unknown KLA .98 .98 1.06 1.06 .91 .97 1.04
ATP 1.00 1.07 1.01 1.06 1.09 .99 1.02
KLA/ATP 1.08 1.06 1.16 1.11 1.16 1.12 1.04
Mm.384
KLA  ATP  ATP+KLA
 197333823 Unknown KLA 1.04 1.03 .99 1.02 1.00 .91 .99
ATP 1.03 .99 1.02 .97 1.00 .91 .97
KLA/ATP 1.03 1.10 1.01 1.01 1.01 .87 1.00
Mm.4364
KLA  ATP  ATP+KLA
 37591174 Unknown KLA .27 .24 .28 .30 .24 .30 .33
ATP .97 .90 .94 .52 1.37 2.32 1.14
KLA/ATP .27 .24 .29 .20 .77 1.62 .76
Mm.47283
8
KLA  ATP  ATP+KLA
 158428111 Unknown KLA 6.79 5.95 4.54 4.42 3.72 2.98 2.26
ATP .97 .84 2.21 3.33 4.29 6.69 1.73
KLA/ATP 6.49 6.68 10.69 10.34 7.43 8.15 5.85
Mm.4864
KLA  ATP  ATP+KLA
 171846241 Unknown KLA .97 1.10 1.04 1.02 1.04 1.09 1.03
ATP 1.03 .96 1.07 1.02 .97 1.05 1.12
KLA/ATP 1.05 .97 .93 1.07 1.02 1.05 1.03
Mm.57127
KLA  ATP  ATP+KLA
 117168292 Unknown KLA 1.20 1.25 1.28 1.18 1.14 1.13 1.12
ATP .98 .95 1.11 1.06 1.05 1.05 1.09
KLA/ATP 1.22 1.24 1.48 1.55 1.40 1.21 1.07
Mm.81698
KLA  ATP  ATP+KLA
 158937287 Unknown KLA .95 1.02 1.04 .98 1.01 1.04 1.08
ATP 1.00 1.03 .97 1.00 1.03 .98 .96
KLA/ATP 1.07 1.00 .94 .98 1.03 1.05 .97
Mm.874
KLA  ATP  ATP+KLA
 6754317 Unknown KLA 24.98 24.87 26.43 39.61 12.88 8.64 1.63
ATP 1.97 3.50 11.05 28.47 38.30 10.44 .65
KLA/ATP 23.45 29.37 58.52 51.77 30.64 14.61 8.63
Mpl
KLA  ATP  ATP+KLA
 NM_010823 myeloproliferative leukemia virus oncogene (Mpl), transcript variant 2, mRNA [NM_010823] KLA 1.07 1.06 1.16 1.13 1.14 .97 1.11
ATP .97 1.00 1.03 1.13 1.14 1.00 1.02
KLA/ATP 1.14 1.21 1.13 1.02 1.07 1.05 1.07
Myc
KLA  ATP  ATP+KLA
 NM_010849 myelocytomatosis oncogene (Myc), mRNA [NM_010849] KLA .38 .31 .45 .45 .49 .35 .33
ATP 1.05 1.09 1.72 4.41 1.28 .45 .76
KLA/ATP .37 .30 .44 1.23 .34 .17 .19
Osm
KLA  ATP  ATP+KLA
 NM_001013365 oncostatin M (Osm), mRNA [NM_001013365] KLA 1.56 1.46 1.46 2.02 1.99 1.68 1.47
ATP 2.40 4.29 10.76 14.66 10.66 9.53 2.21
KLA/ATP 1.94 3.15 10.63 13.85 12.20 11.12 5.30
Osmr
KLA  ATP  ATP+KLA
 NM_011019 oncostatin M receptor (Osmr), mRNA [NM_011019] KLA 1.18 1.26 1.23 1.16 1.13 1.08 1.03
ATP 1.02 1.00 1.04 1.04 1.10 1.07 1.04
KLA/ATP 1.21 1.17 1.17 1.14 1.19 1.10 1.08
Pias1
KLA  ATP  ATP+KLA
 NM_019663 protein inhibitor of activated STAT 1 (Pias1), mRNA [NM_019663] KLA 1.60 1.58 1.85 1.69 1.49 1.22 1.00
ATP 1.09 1.10 .93 .86 .96 .68 .88
KLA/ATP 1.64 1.41 1.29 1.32 1.37 1.01 1.26
Pias2
KLA  ATP  ATP+KLA
 NM_008602 protein inhibitor of activated STAT 2 (Pias2), mRNA [NM_008602] KLA .85 .84 .82 .87 .80 1.05 1.03
ATP .88 .95 1.02 .86 .93 1.17 1.16
KLA/ATP .76 .83 .91 .77 .93 1.15 1.16
Pias3
KLA  ATP  ATP+KLA
 NM_018812 protein inhibitor of activated STAT 3 (Pias3), transcript variant 2, mRNA [NM_018812] KLA .91 .88 .88 .80 .78 .94 .99
ATP 1.07 1.25 .89 .96 .60 .68 .83
KLA/ATP 1.00 .89 .76 .79 .62 .71 .93
Pias3
KLA  ATP  ATP+KLA
 NM_146135 protein inhibitor of activated STAT 3 (Pias3), transcript variant 1, mRNA [NM_146135] KLA .70 .67 .70 .62 .79 1.00 .86
ATP 1.07 1.13 .88 .77 .50 .66 .80
KLA/ATP .81 .71 .69 .67 .64 .60 1.06
Pias4
KLA  ATP  ATP+KLA
 NM_021501 protein inhibitor of activated STAT 4 (Pias4), mRNA [NM_021501] KLA .97 1.13 1.26 1.38 1.87 1.63 1.62
ATP 1.12 1.30 .89 1.24 1.93 1.64 1.92
KLA/ATP 1.33 1.11 .74 1.30 1.61 2.07 2.69
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Pim1
KLA  ATP  ATP+KLA
 AK047301 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930046O16 product:proviral integration site 1, full insert sequence [AK047301] KLA 2.63 2.33 2.46 2.47 2.14 1.82 1.80
ATP 1.34 1.58 2.29 3.31 2.89 2.05 1.28
KLA/ATP 2.66 3.43 3.98 3.91 3.15 2.29 1.92
Pim1
KLA  ATP  ATP+KLA
 NM_008842 proviral integration site 1 (Pim1), mRNA [NM_008842] KLA 7.50 7.48 6.49 7.27 6.79 4.75 4.07
ATP 4.88 6.65 6.18 14.11 9.41 5.26 1.96
KLA/ATP 9.06 11.40 8.53 18.67 10.67 6.01 6.18
Prl
KLA  ATP  ATP+KLA
 NM_011164 prolactin (Prl), mRNA [NM_011164] KLA 1.01 1.00 1.06 1.02 1.05 .96 .97
ATP .99 1.02 .97 .98 .97 .95 1.00
KLA/ATP 1.00 1.01 1.00 .97 .96 .87 .95
Prlr
KLA  ATP  ATP+KLA
 AK083198 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630026G18 product:unclassifiable, full insert sequence [AK083198] KLA .99 1.07 1.00 .95 1.01 .90 1.01
ATP 1.02 .94 .97 1.00 .97 .94 .96
KLA/ATP .98 .94 .96 .96 .99 1.07 1.02
Prlr
KLA  ATP  ATP+KLA
 AK087727 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330012C04 product:hypothetical protein, full insert sequence [AK087727] KLA 1.03 1.00 .99 1.01 1.02 1.04 .99
ATP 1.00 .95 1.13 1.06 .97 .98 1.04
KLA/ATP .97 1.01 .88 1.02 1.01 1.03 1.05
Prlr
KLA  ATP  ATP+KLA
 NM_011169 prolactin receptor (Prlr), mRNA [NM_011169] KLA .93 1.03 1.12 1.06 1.05 1.14 1.15
ATP .95 .99 1.11 1.13 1.06 1.19 1.18
KLA/ATP 1.02 1.01 1.05 1.10 1.10 1.21 1.07
Ptpn11
KLA  ATP  ATP+KLA
 NM_001109992 protein tyrosine phosphatase, non-receptor type 11 (Ptpn11), transcript variant 2, mRNA [NM_001109992] KLA 1.52 1.71 1.59 1.78 1.62 1.57 1.35
ATP 1.04 .93 .86 .79 1.09 1.95 1.90
KLA/ATP 1.59 1.61 1.45 1.11 1.18 1.82 3.02
Ptpn11
KLA  ATP  ATP+KLA
 NM_011202 protein tyrosine phosphatase, non-receptor type 11 (Ptpn11), transcript variant 1, mRNA [NM_011202] KLA 1.32 1.28 1.17 1.21 1.18 1.06 1.05
ATP .97 .77 .71 .56 .90 1.27 1.04
KLA/ATP 1.22 1.21 1.02 .70 .96 1.06 .94
Ptpn6
KLA  ATP  ATP+KLA
 NM_001077705 protein tyrosine phosphatase, non-receptor type 6 (Ptpn6), transcript variant 2, mRNA [NM_001077705] KLA .87 .90 1.03 1.05 1.83 1.96 2.34
ATP 1.06 1.09 .94 1.08 .51 .34 1.04
KLA/ATP .98 .93 .71 .95 .67 .64 1.44
Ptpn6
KLA  ATP  ATP+KLA
 NM_013545 protein tyrosine phosphatase, non-receptor type 6 (Ptpn6), transcript variant 1, mRNA [NM_013545] KLA 1.24 1.20 1.46 1.42 2.43 2.27 2.10
ATP 1.18 1.20 1.10 1.49 .80 .58 1.09
KLA/ATP 1.36 1.42 1.27 1.66 1.12 .87 1.46
Ptpn6
KLA  ATP  ATP+KLA
 S63763 gb|me/Hcph (mev)=viable motheaten/hematopoietic cell protein-tyrosine phosphatase {insertion} [mice, mRNA Partial Mutant, 120 nt]. [S63763] KLA 1.06 1.03 1.12 1.14 1.11 1.01 1.09
ATP 1.03 .97 .96 .90 .89 1.17 1.76
KLA/ATP 1.07 1.00 1.03 .98 1.00 1.29 1.44
Socs1
KLA  ATP  ATP+KLA
 NM_009896 suppressor of cytokine signaling 1 (Socs1), mRNA [NM_009896] KLA 27.36 22.16 20.64 23.08 17.74 21.71 10.12
ATP .91 .72 2.03 12.69 9.16 19.87 6.80
KLA/ATP 26.70 24.56 28.15 31.28 26.32 29.95 22.51
Socs2
KLA  ATP  ATP+KLA
 AK033206 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030460M17 product:hypothetical SH2 motif [AK033206] KLA 1.08 1.11 1.22 1.13 1.11 1.08 .97
ATP .98 .97 1.03 1.03 1.29 1.30 1.29
KLA/ATP 1.06 1.09 1.07 1.33 2.01 1.85 1.98
Socs2
KLA  ATP  ATP+KLA
 NM_007706 suppressor of cytokine signaling 2 (Socs2), mRNA [NM_007706] KLA 2.03 2.28 2.61 1.98 1.59 1.72 1.28
ATP 1.04 1.04 1.05 1.17 2.11 3.47 3.02
KLA/ATP 2.18 1.92 1.71 2.33 3.37 5.81 4.64
Socs3
KLA  ATP  ATP+KLA
 NM_007707 suppressor of cytokine signaling 3 (Socs3), mRNA [NM_007707] KLA 7.56 6.68 6.29 7.36 6.47 7.03 5.33
ATP 1.51 1.75 4.63 6.27 6.92 7.74 4.64
KLA/ATP 6.82 6.77 9.19 8.32 9.51 8.98 8.33
Socs4
KLA  ATP  ATP+KLA
 AK080408 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730004F22 product:unclassifiable, full insert sequence [AK080408] KLA .89 .90 .87 .74 .87 1.05 .98
ATP 1.01 .97 1.11 .76 1.00 .82 1.11
KLA/ATP .80 .82 .82 .70 1.00 .80 .76
Socs4
KLA  ATP  ATP+KLA
 NM_080843 suppressor of cytokine signaling 4 (Socs4), mRNA [NM_080843] KLA 1.31 1.29 1.45 1.31 1.42 1.90 2.37
ATP 1.02 1.16 1.31 1.39 1.86 2.43 2.69
KLA/ATP 1.33 1.24 1.26 1.31 1.39 2.94 3.73
Socs5
KLA  ATP  ATP+KLA
 NM_019654 suppressor of cytokine signaling 5 (Socs5), mRNA [NM_019654] KLA .37 .34 .33 .32 .29 .43 .66
ATP 1.13 1.24 1.29 1.17 .67 .52 .60
KLA/ATP .44 .37 .41 .39 .41 .37 .37
Socs7
KLA  ATP  ATP+KLA
 NM_138657 suppressor of cytokine signaling 7 (Socs7), mRNA [NM_138657] KLA 1.86 1.79 2.05 1.76 1.69 1.24 .99
ATP 1.07 1.08 1.11 1.14 1.29 1.82 1.71
KLA/ATP 1.96 1.99 1.66 1.80 1.49 2.04 2.09
Sos1
KLA  ATP  ATP+KLA
 NM_009231 Son of sevenless homolog 1 (Drosophila) (Sos1), mRNA [NM_009231] KLA 2.36 2.40 3.42 3.15 2.78 1.81 1.71
ATP .99 1.00 .99 1.15 1.14 1.25 1.24
KLA/ATP 2.41 2.26 1.95 2.44 1.47 1.66 1.37
Sos2
KLA  ATP  ATP+KLA
 XM_127051 gb|PREDICTED: Mus musculus Son of sevenless homolog 2 (Drosophila) (Sos2), mRNA [XM_127051] KLA .81 .77 .79 .92 1.04 1.06 1.20
ATP 1.00 1.00 1.09 .79 .68 .81 .94
KLA/ATP .77 .69 .71 .60 .64 .77 1.07
Spred1
KLA  ATP  ATP+KLA
 AK017680 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730461F13 product:hypothetical protein, full insert sequence [AK017680] KLA 1.76 1.67 1.75 1.71 1.57 1.18 .94
ATP 1.13 .96 .73 .64 .57 .72 .72
KLA/ATP 1.81 1.71 1.24 .91 .67 .62 .88
Spred1
KLA  ATP  ATP+KLA
 NM_033524 sprouty protein with EVH-1 domain 1, related sequence (Spred1), mRNA [NM_033524] KLA 3.10 3.17 4.03 3.65 3.12 2.26 1.78
ATP 1.06 1.15 .96 1.22 .79 1.03 1.13
KLA/ATP 3.25 3.21 2.41 2.93 1.14 1.17 2.31
Spred2
KLA  ATP  ATP+KLA
 AK157817 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130063B07 product:sprouty protein with EVH-1 domain 2, related sequence, full insert sequence [AK157817] KLA .35 .35 .29 .33 .51 .88 1.29
ATP 1.03 1.17 .96 .83 .43 .50 .99
KLA/ATP .38 .37 .28 .33 .26 .40 1.02
Spred2
KLA  ATP  ATP+KLA
 NM_033523 sprouty-related, EVH1 domain containing 2 (Spred2), mRNA [NM_033523] KLA .63 .58 .46 .61 .63 .92 1.30
ATP 1.07 1.18 .87 .96 .53 .66 .95
KLA/ATP .61 .58 .48 .63 .48 .57 .95
Spred3
KLA  ATP  ATP+KLA
 NM_182927 sprouty-related, EVH1 domain containing 3 (Spred3), mRNA [NM_182927] KLA .80 .81 .80 .90 .90 1.02 1.01
ATP 1.08 1.12 1.01 1.25 1.03 .89 1.35
KLA/ATP .87 .83 .83 .97 .89 .84 1.15
Spry1
KLA  ATP  ATP+KLA
 NM_011896 sprouty homolog 1 (Drosophila) (Spry1), mRNA [NM_011896] KLA 1.08 1.06 .92 1.10 1.20 1.25 1.30
ATP 1.67 3.51 5.69 8.37 3.58 1.40 .87
KLA/ATP 1.05 1.27 1.32 2.21 1.25 1.13 .81
Spry2
KLA  ATP  ATP+KLA
 NM_011897 sprouty homolog 2 (Drosophila) (Spry2), mRNA [NM_011897] KLA .95 .91 .98 1.07 .98 .99 .82
ATP 1.15 1.28 2.21 3.17 2.15 1.12 1.07
KLA/ATP 1.02 1.16 2.43 2.94 1.93 1.09 .88
Spry3
KLA  ATP  ATP+KLA
 NM_001030293 sprouty homolog 3 (Drosophila) (Spry3), mRNA [NM_001030293] KLA .89 .86 .82 .84 .81 .71 .83
ATP .99 1.05 1.06 1.11 1.04 1.22 1.09
KLA/ATP .79 .84 .77 .87 .94 1.06 .86
Spry4
KLA  ATP  ATP+KLA
 NM_011898 sprouty homolog 4 (Drosophila) (Spry4), mRNA [NM_011898] KLA 1.03 1.02 1.04 .99 1.00 .97 .96
ATP 1.01 .99 1.02 .97 1.00 .96 1.29
KLA/ATP 1.00 1.02 1.00 1.04 .98 1.02 1.01
Stam
KLA  ATP  ATP+KLA
 NM_011484 signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 (Stam), mRNA [NM_011484] KLA 1.04 .95 1.11 1.01 .74 .84 1.27
ATP 1.08 1.16 1.41 1.31 2.25 2.07 1.27
KLA/ATP 1.07 1.13 1.25 1.21 1.44 1.59 1.36
Stam2
KLA  ATP  ATP+KLA
 NM_019667 signal transducing adaptor molecule (SH3 domain and ITAM motif) 2 (Stam2), mRNA [NM_019667] KLA 1.23 1.18 1.21 1.17 1.52 1.73 2.04
ATP 1.11 1.18 1.16 1.87 3.04 2.11 3.01
KLA/ATP 1.23 1.38 1.15 2.05 2.81 2.66 6.00
Stat1
KLA  ATP  ATP+KLA
 NM_009283 signal transducer and activator of transcription 1 (Stat1), mRNA [NM_009283] KLA 2.90 2.72 3.00 3.64 4.58 6.51 5.58
ATP 1.01 .92 .89 .72 .51 2.22 3.07
KLA/ATP 2.73 2.65 2.34 1.95 1.99 4.70 8.66
Stat2
KLA  ATP  ATP+KLA
 NM_019963 signal transducer and activator of transcription 2 (Stat2), mRNA [NM_019963] KLA 5.64 4.80 4.99 6.48 6.28 9.50 5.36
ATP .90 .80 1.03 .66 .97 4.90 4.07
KLA/ATP 4.47 4.88 6.34 4.27 6.76 9.49 11.43
Stat3
KLA  ATP  ATP+KLA
 NM_213659 signal transducer and activator of transcription 3 (Stat3), transcript variant 1, mRNA [NM_213659] KLA 4.36 4.42 4.67 6.02 4.95 3.45 1.46
ATP 1.01 .97 1.07 1.17 2.47 4.04 1.47
KLA/ATP 4.02 4.57 6.65 6.51 7.06 7.39 3.61
Stat4
KLA  ATP  ATP+KLA
 NM_011487 signal transducer and activator of transcription 4 (Stat4), mRNA [NM_011487] KLA 1.03 1.06 1.12 1.22 .96 .75 .28
ATP .97 1.04 .98 1.26 1.12 1.50 .40
KLA/ATP .96 1.10 1.05 1.54 1.50 2.82 .89
Stat5a
KLA  ATP  ATP+KLA
 NM_011488 signal transducer and activator of transcription 5A (Stat5a), mRNA [NM_011488] KLA 8.23 8.24 6.89 4.88 4.35 1.98 1.01
ATP 1.07 1.14 1.07 1.26 3.23 3.14 1.52
KLA/ATP 8.70 9.53 7.33 6.68 4.32 2.73 1.72
Stat5b
KLA  ATP  ATP+KLA
 AK137889 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130035C01 product:unclassifiable, full insert sequence. [AK137889] KLA 1.10 1.01 .98 .90 1.03 .93 .88
ATP .90 .87 .61 .69 1.01 .97 .89
KLA/ATP 1.12 1.00 .87 .85 .95 1.07 .83
Stat5b
KLA  ATP  ATP+KLA
 NM_011489 signal transducer and activator of transcription 5B (Stat5b), transcript variant 1, mRNA [NM_011489] KLA 2.91 2.81 3.42 2.69 2.23 1.95 1.32
ATP .99 1.04 1.16 .97 1.00 1.84 2.09
KLA/ATP 2.96 3.05 3.17 2.99 1.86 1.87 3.40
Stat6
KLA  ATP  ATP+KLA
 NM_009284 signal transducer and activator of transcription 6 (Stat6), mRNA [NM_009284] KLA .77 .77 .70 .64 .71 .84 1.13
ATP 1.13 1.12 .65 .79 .65 .66 1.09
KLA/ATP .89 .79 .51 .60 .54 .68 1.15
Tpo
KLA  ATP  ATP+KLA
 NM_009417 thyroid peroxidase (Tpo), mRNA [NM_009417] KLA 1.05 1.05 .87 1.01 1.00 1.03 1.04
ATP 1.03 .95 .99 1.02 1.00 1.00 .91
KLA/ATP 1.01 .99 1.01 1.01 .93 .96 .93
Tslp
KLA  ATP  ATP+KLA
 NM_021367 thymic stromal lymphopoietin (Tslp), mRNA [NM_021367] KLA 1.27 1.32 1.20 1.11 1.16 .95 .85
ATP 1.04 .97 1.02 .98 1.27 1.31 .86
KLA/ATP 1.26 1.42 1.11 1.32 1.26 1.19 .93
Tyk2
KLA  ATP  ATP+KLA
 NM_018793 tyrosine kinase 2 (Tyk2), mRNA [NM_018793] KLA 2.91 2.95 3.42 3.26 3.85 2.35 1.42
ATP 1.09 1.01 .68 .64 .59 .86 1.10
KLA/ATP 2.95 3.04 2.23 1.82 1.24 1.27 2.09
Zfp91-cn
tf
KLA  ATP  ATP+KLA
 NM_001039718 zinc finger protein 91, ciliary neurotrophic factor transcription unit (Zfp91-cntf), mRNA [NM_001039718] KLA 1.28 1.20 1.20 1.31 1.23 1.38 1.21
ATP 1.22 1.17 2.26 4.25 4.44 3.73 1.90
KLA/ATP 1.44 1.39 2.22 3.89 5.86 4.63 3.25